Diagnostic accuracy of pericardial fluid cytology: An analysis of 53 specimens from 44 consecutive patients

Diagnostic Cytopathology

Volumn 15, Issue 3, 1996, Pages 197-204

  Malamou Mitsi, Vassiliki D ^a   Zioga, Aikaterini P ^a   Agnantis, Niki J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Diagnostic accuracy; Immunocytochemistry; Pericardial cytology; Pericardial effusions

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LARGE CELL CARCINOMA; MALE; METASTASIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PERICARDIAL EFFUSION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0029828298     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199609)15:3<197::AID-DC5>3.0.CO;2-E     Document Type: Article

References (54)

1. Theologides A. Neoplastic cardiac tamponade. Semin Oncol 1978;5: 181-192.
2. Koss LG. Effusions in the absence of cancer, Effusions in the presence of cancer. In: Koss LG, ed. Diagnostic cytology and its histopathologic bases. 4th ed. Philadelphia and Toronto: JB Lippincott, 1992:1082-1184.
3. Naylor B. Pleural, peritoneal and pericardial fluids. In: Bibbo M, ed. Comprehensive cytopathology. Philadelphia: WB Saunders, Harcourt Brace Jovanavich, 1991:541-614.
4. Ryan GB, Grobety J, Majno G. Mesothelial injury and recovery. Am J Pathol 1973;71:93-102.
5. Bisel HF, Wroblewski F, La Due JS. Incidence and clinical manifestations of cardiac metastasis. JAMA 1953;153:712-715.
6. Scott RW, Garvin CF. Tumors of the heart and pericardium. Am Heart J 1939;17:431-436.
7. Kobayashi Y, Takeda S, Yamamoto T, Goi S. Cytologic detection of malignant mesothelioma of the pericardium. Acta Cytol 1978;22:344-349.
8. Becker SN, Papin DW, Rosenthal DL. Mesothelial papilloma: a case of mistaken identity in a pericardial effusion. Acta Cytol 1976;20:266-268.
9. Sytman AL, MacAlpin RN. Primary pericardial mesothelioma: report of 2 cases and review of the literature. Am Heart J 1971;81:760-769.
10. Marsten JL, Cooper AG, AnKeney JL. Acute cardiac tamponade due to performation of a benign mediastinal teratoma into the pericardial sac: review of cardiovascular manifestations of mediastinal teratomas. J Thorac Cardiovasc Surg 1966;51:700-707.
11. Pozniak AL, Thomas RD, Hobbs CB, Lever JV. Primary malignant lymphoma of the heart. Antemortem cytologic diagnosis. Acta Cytol 1986;30:662-664.
12. Venegas RJ, Sun NCJ. Cardiac tamponade as a presentation of malignant thymoma. Acta Cytol 1988;32:257-262.
13. Rodriguez LI, Casal IL, Carballo C, Lado LF. Pleuropericardial effusion as the initial manifestation of malignant thymoma. Med Clin (Barc) 1985;84:377-378.
14. Yardi HM, Hajdu SI, Melamed MR. Cytopathology of pericardial effusions. Acta Cytol 1980;24:401-412.
15. Wiener HG, Kristensen IB, Haubek A, Kristensen B, Baandrup U. The diagnostic value of pericardial cytology. An analysis of 95 cases. Acta Cytol 1991;35:149-153.
16. Martini N, Freiman AH, Watson RC, Hilaris BS. Malignant pericardial effusion. NY State J Med 1976;76:719-721.
17. Adendle AD, Edwards JE. Clinical and pathological features of metastatic neoplasms of the pericardium. Chest 1982;81:166-167.
18. Peterson CD, Robinson WA, Jurnick JE. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci 1976;272: 161-165.
19. Zipf RE, Johnston WW. The role of cytology in the evaluation of pericardial effusions. Chest 1972;62:593-596.
20. Pinto MM. Malignant pericardial effusion and cardiac tamponade. Acta Cytol 1986;30:657-661.
21. Krikorian JG, Hancock EW. Pericardiocentesis. Am J Med 1978;65: 808-814.
22. Domagala W, Koss LG. Configuration of surfaces of cells in effusions by scanning electron microscopy. In: Koss LG, Coleman DV, eds. Advances in clinical cytology. London: Butterworths, 1981:270-313.
23. Kobzik L, Antman KH, Warhol MJ. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy. Acta Cytol 1985;29:219-225.
24. Schneller J, Eppich E, Greenebaum E, Elequin F, Sherman A, Wersto R, Koss LG. Flow cytometry and Feulgen cytophotometry in evaluation of effusions. Cancer 1987;59:1307-1313.
25. Rijken A, Dekker A, Taylor S, Hoffman P, Blank M, Krause JR. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination. Am J Clin Pathol 1991;95:6-12.
26. Singh G, Dekker A, Ladouli CT. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol 1978;22: 487-189.
27. Mottolese M, Cianciulli A, Venturo I, Perrone Donnorso R, Salzano M, Benevolo M, Bigotti G, Natali PG. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture. Diagn Cytopathol 1992;8: 153-160.
28. Meyers FJ, Lewis JP, Marianos S. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions. Cancer 1986;58: 1479-1483.
29. To A, Dearnaley DP, Ormerod MG, Canti G, Coleman DV. Epithelial membrane antigen. Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol 1982;78:214-219.
30. Walts AE, Said JW, Shintaku IP. Epithelial membrane antigen in the cytodiagnosis of effusions and aspirates. Diagn Cytopathol 1987;3:41-49.
31. Silverman JF, Nance K, Phillips B, Noms HT. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions. Diagn Cytopathol 1987;3:134-140.
32. Mason MR, Bedrossian CWM, Fahey CA. Value of immunocytochemistry in the study of malignant effusions. Diagn Cytopathol 1987;3: 215-221.
33. Duggan MA, Masters CB, Alexander F. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin. Acta Cytol 1987;31: 807-814.
34. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989;13:276-291.
35. Diaz-Arias AA, Loy TS, Bickel JT, Chapman RK. Utility of BER-ER4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study in 232 cases. Diagn Cytopathol 1993;9:516-521.
36. Tello JW, Szpak CA, Schlom J, Johnston WW. A comparative study of the immunocytochemical staining of cell blocks and cytocentrifuge specimens with monoclonal antibody B72.3. Acta Cytol 1988;32: 772-773.
37. Loy TS, Diaz-Arias AA, Bickel JT. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases. Mod Pathol 1990;3:294-297.
38. Spriggs AI, Boddington MM. Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluids. In: Gresham GA, ed. Current histopathology series. Vol. 14. Dordrecht: Kluwer Academic Publishers, 1989; 1-22.
39. Cardoso PL. A critical evaluation of 3,000 cytologic analyses of pleural fluid, ascitic fluid and pericardial fluid. Acta Cytol 1966;10:455-460.
40. Jarvi OH, Kunnas RJ, Laitio MT, Tyrkkö JES. The accuracy and significance of cytologic cancer diagnosis of pleural effusions. Acta Cytol 1972;16:152-158.
41. Spieler P, Gloor F. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with diagnostic accuracy on small histologic biopsies. Acta Cytol 1985;29:753-767.
42. Murphy WM, Ng ABP. Determination of primary site by examination of cancer cells in body fluids. Am J Clin Pathol 1972;58:479-488.
43. Johnston WW. The malignant pleural effusion. A review of cytopathology diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-909.
44. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97.
45. Triol JH, Conston AS, Chandler SV. Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital. Acta Cytol 1984;28:37-45.
46. Hsu C. Cytologic detection of malignancy in pleural effusion. A review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987;3:8-12.
47. Koprowska I. Exfoliative cytology in study of ascites tumors. Ann NY Acad Sci 1956;63:793-817.
48. Stewart R, Gupta RK. Fine-catheter aspiration cytology of peritoneal cavity: a new system with potential for oncologic diagnosis. Diagn Cytopathol 1987;3:339-341.
49. Ramsey SJ, Tweeddale DN, Bryant LR, Braunstein H. Cytologic features of pericardial mesothelium. Acta Cytol 1970;14:283-290.
50. Flannery EP, Gregoratos G, Corder MP. Pericardial effusions in patients with malignant disease. Arch Intern Med 1975;135:976-977.
51. Grunze H. The comparative diagnostic accuracy, efficiency and specificity of cytologic techniques used in the diagnosis of malignant neoplasm in serous effusions of the pleural and pericardial cavities. Acta Cytol 1964;8:150-163.
52. Light RW, Erosan VS, Ball WC. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973;132:854-860.
53. Monte SA, Ehya H, Lang WR. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987;31:448-452.
54. Van de Molegraft FJJM, Vooijs GP. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis. Acta Cytol 1988;32:183-187.